Aflac (NYSE:AFL) Major Shareholder Sells $2,372,310.00 in Stock

Aflac Incorporated (NYSE:AFL) major shareholder Post Holdings Co. Ltd. Japan sold 21,500 shares of the firm’s stock in a transaction dated Monday, April 6th. The stock was sold at an average price of $110.34, for a total value of $2,372,310.00. Following the completion of the transaction, the insider directly owned 51,913,300 shares in the company, valued at $5,728,113,522. This trade represents a 0.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Post Holdings Co. Ltd. Japan also recently made the following trade(s):

• On Thursday, April 2nd, Post Holdings Co. Ltd. Japan sold 20,100 shares of Aflac stock. The stock was sold at an average price of $110.20, for a total value of $2,215,020.00.
• On Wednesday, April 1st, Post Holdings Co. Ltd. Japan sold 19,600 shares of Aflac stock. The stock was sold at an average price of $109.85, for a total value of $2,153,060.00.
• On Wednesday, March 25th, Post Holdings Co. Ltd. Japan sold 14,200 shares of Aflac stock. The stock was sold at an average price of $107.03, for a total value of $1,519,826.00.
• On Monday, March 23rd, Post Holdings Co. Ltd. Japan sold 15,000 shares of Aflac stock. The stock was sold at an average price of $106.78, for a total value of $1,601,700.00.
• On Friday, March 20th, Post Holdings Co. Ltd. Japan sold 16,800 shares of Aflac stock. The stock was sold at an average price of $106.47, for a total value of $1,788,696.00.
• On Thursday, March 19th, Post Holdings Co. Ltd. Japan sold 10,100 shares of Aflac stock. The stock was sold at an average price of $107.41, for a total value of $1,084,841.00.
• On Wednesday, March 18th, Post Holdings Co. Ltd. Japan sold 12,200 shares of Aflac stock. The stock was sold at an average price of $108.43, for a total value of $1,322,846.00.
• On Tuesday, March 17th, Post Holdings Co. Ltd. Japan sold 15,700 shares of Aflac stock. The stock was sold at an average price of $109.77, for a total value of $1,723,389.00.
• On Friday, March 13th, Post Holdings Co. Ltd. Japan sold 17,400 shares of Aflac stock. The stock was sold at an average price of $109.14, for a total value of $1,899,036.00.
• On Thursday, March 12th, Post Holdings Co. Ltd. Japan sold 17,900 shares of Aflac stock. The stock was sold at an average price of $109.60, for a total value of $1,961,840.00.

Aflac Stock Up 0.1%

NYSE AFL opened at $110.39 on Wednesday. The stock’s 50-day moving average price is $111.31 and its 200-day moving average price is $110.45. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 52 week low of $96.95 and a 52 week high of $119.32. The company has a market capitalization of $56.87 billion, a P/E ratio of 16.05, a price-to-earnings-growth ratio of 3.62 and a beta of 0.66.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a return on equity of 14.35% and a net margin of 21.24%.The business had revenue of $4.28 billion for the quarter, compared to analysts’ expectations of $4.45 billion. During the same quarter in the prior year, the business posted $1.57 EPS. The business’s revenue for the quarter was down 9.6% compared to the same quarter last year. On average, equities research analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $113.00 target price on shares of Aflac in a research report on Thursday, March 26th. TD Cowen reiterated a “hold” rating on shares of Aflac in a research report on Monday, December 22nd. Piper Sandler upgraded Aflac to a “strong-buy” rating in a research report on Thursday, April 2nd. Raymond James Financial reiterated an “outperform” rating and set a $119.00 target price (up from $110.00) on shares of Aflac in a research report on Tuesday, December 30th. Finally, Wells Fargo & Company increased their target price on Aflac from $109.00 to $118.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, Aflac currently has an average rating of “Hold” and an average price target of $112.00.

Hedge Funds Weigh In On Aflac

Institutional investors have recently added to or reduced their stakes in the company. True Wealth Design LLC grew its holdings in Aflac by 188.5% during the 3rd quarter. True Wealth Design LLC now owns 225 shares of the financial services provider’s stock valued at $25,000 after buying an additional 147 shares in the last quarter. Quarry LP purchased a new position in Aflac during the 4th quarter valued at approximately $25,000. Nalls Sherbakoff Group LLC purchased a new position in Aflac during the 4th quarter valued at approximately $29,000. Navalign LLC purchased a new position in Aflac during the 4th quarter valued at approximately $32,000. Finally, Darwin Wealth Management LLC purchased a new position in Aflac during the 2nd quarter valued at approximately $33,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.